
Already a subscriber?
Log In
Become a member to see contact information for 731: Company sponsored indrect comparison concludes the companyâEURs product is better for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage.
Cast | + Add Cast |
0 cast members |
Contribute to this section by adding a cast member